Climb Bio Q3 EPS $(0.13) Up From $(0.15) YoY
Climb Bio Q3 EPS $(0.13) Up From $(0.15) YoY
Climb Bio第三季每股收益爲$(0.13),比去年同期$(0.15)有所提高
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.13) per share. This is a 13.33 percent increase over losses of $(0.15) per share from the same period last year.
Climb Bio(納斯達克:CLYM)報告每股虧損$(0.13)。這比去年同期每股虧損$(0.15)增加了13.33%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。